Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07474675 · ClinicalTrials.gov registry record
Evaluation of a Point-of-care Lateral Flow Assay in Glial Fibrillary Acidic Protein (GFAP) and D-dimer in Diagnosis of Large Vessel Occlusion Acute Ischemic Stroke in a Pediatric Hospital
A clinical trial, sponsored by Boston Children's Hospital.
- Not yet
- Registry status
- 250
- Enrollment target
NCT07474675 is a clinical trial that has not yet begun recruiting, run by Boston Children's Hospital. The registered enrollment target is 250 participants.
The verdict
NCT07474675 has not yet begun recruiting, sponsored by Boston Children's Hospital.
- NOT YET RECRUITING
- Registry status
- 250 participants
- Enrollment target
Study Summary
The goal of this study is to test the efficacy of a rapid bedside blood test in determining if a stroke is happening in children who present to the emergency department with stroke symptoms. The main questions it aims to answer are: * To determine the sensitivity of detecting a large vessel occlusion (LVO) as the etiology of acute ischemic stroke (AIS) in a pediatric population using a point-of-care blood-based assay (LVOne). * To determine the positive predictive value (PPV) of LVOne in a pediatric population Participants will: * Provide a small sample of blood to be used to test the accuracy of the device. * Participants will still receive all standard of care work-up for stroke, which could include computed tomography/magnetic resonance imaging (CT/MRI).
Interventions
- DEVICE Point of Care Rapid Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2026-03 |
| Est. Completion | 2028-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07474675
The ClinicalTrials.gov registry entry for NCT07474675 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Point of Care Rapid Assay is the first listed.
NCT07474675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07474675 about?
NCT07474675 is a clinical study titled "Evaluation of a Point-of-care Lateral Flow Assay in Glial Fibrillary Acidic Protein (GFAP) and D-dimer in Diagnosis of Large Vessel Occlusion Acute Ischemic Stroke in a Pediatric Hospital". The goal of this study is to test the efficacy of a rapid bedside blood test in determining if a stroke is happening in children who present to the emergency department with stroke symptoms. The main questions it aims to answer are: * To determine the sensitivity of detecting a large vessel occlusi...
What is the current status of trial NCT07474675?
This trial is currently not yet recruiting. The enrollment target is 250 participants. The study started on 2026-03. Estimated completion is 2028-07.
What interventions are being tested in trial NCT07474675?
The interventions under investigation include: Point of Care Rapid Assay (DEVICE).
Who is sponsoring clinical trial NCT07474675?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.